Sabatolimab (anti-TIM-3) | Immunology & Inflammation related

Sabatolimab (anti-TIM-3) (MBG453, NVP-MBG453) is a high-affinity, humanized IgG4 antibody targeting TIM-3 on the surface of T-cells.

Selleck's Sabatolimab (anti-TIM-3) has been cited by 0 Publication

1 Customer Review

Batch: Purity: 99.44% Protein concentration: 6.3mg/ml Endotoxin Level: ＜1EU/mg

99.44

Description	Sabatolimab (anti-TIM-3) (MBG453, NVP-MBG453) is a high-affinity, humanized IgG4 antibody targeting TIM-3 on the surface of T-cells.

References
[1] Andrew M. Brunner, MD, et al. Blood (2020) 136 (Supplement 1): 1–2.

References

CAS No.	2252262-24-9
Molecular Weight	145 KD
Isotype	Human IgG4, κ
Application	Sabatolimab (anti-TIM-3)
Source	CHO cells
Purification	Protein G
Sterility	0.2 μM filtered
Formulation	PBS Buffer, PH 7.4
Storage (From the date of receipt)	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.

If you have any other enquiries, please leave a message.

* Indicates a Required Field